Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Oral Steroids in Endoscopic Sinus Surgery
NCT05095961Phase 3Withdrawn
- Sponsor
- Loma Linda University
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, single-blind trial of prednisone in chronic rhinosinusitis without nasal polyps (CRSsNP) (2 arms), sponsored by Loma Linda University. Primary endpoints: Intra-operative blood loss and Surgical field visibility. Planned start Mar 2023; status: withdrawn.
02
Drugs
prednisone
03
Conditions
chronic rhinosinusitis without nasal polyps (CRSsNP)
Beyond the preview
Go deeper on NCT05095961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095961.